NASDAQ:RCEL AVITA Medical (RCEL) Stock Forecast, Price & News $14.61 +0.03 (+0.21%) (As of 09/29/2023 08:53 PM ET) Add Compare Share Share Today's Range$14.35▼$14.8150-Day Range$13.84▼$20.7952-Week Range$4.41▼$21.70Volume251,900 shsAverage Volume196,484 shsMarket Capitalization$372.26 millionP/E RatioN/ADividend YieldN/APrice Target$28.40 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media AVITA Medical MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside94.4% Upside$28.40 Price TargetShort InterestBearish3.80% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.60Based on 4 Articles This WeekInsider TradingAcquiring Shares$89,650 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.50) to ($1.30) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.94 out of 5 starsMedical Sector689th out of 970 stocksSurgical & Medical Instruments Industry76th out of 99 stocks 3.5 Analyst's Opinion Consensus RatingAVITA Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $28.40, AVITA Medical has a forecasted upside of 94.4% from its current price of $14.61.Amount of Analyst CoverageAVITA Medical has only been the subject of 4 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.80% of the float of AVITA Medical has been sold short.Short Interest Ratio / Days to CoverAVITA Medical has a short interest ratio ("days to cover") of 5.4.Change versus previous monthShort interest in AVITA Medical has recently increased by 0.14%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAVITA Medical does not currently pay a dividend.Dividend GrowthAVITA Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for RCEL. Previous Next 2.0 News and Social Media Coverage News SentimentAVITA Medical has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for AVITA Medical this week, compared to 1 article on an average week.MarketBeat FollowsOnly 2 people have added AVITA Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AVITA Medical insiders have bought 34.98% more of their company's stock than they have sold. Specifically, they have bought $89,650.00 in company stock and sold $66,417.00 in company stock.Percentage Held by InsidersOnly 1.96% of the stock of AVITA Medical is held by insiders.Percentage Held by InstitutionsOnly 29.88% of the stock of AVITA Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for AVITA Medical are expected to grow in the coming year, from ($1.50) to ($1.30) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVITA Medical is -12.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVITA Medical is -12.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVITA Medical has a P/B Ratio of 4.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AVITA Medical (NASDAQ:RCEL) StockAVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Read More RCEL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCEL Stock News HeadlinesSeptember 27, 2023 | americanbankingnews.comAVITA Medical's (RCEL) Overweight Rating Reiterated at Cantor FitzgeraldSeptember 25, 2023 | finance.yahoo.comAVITA Medical Receives Best Product Award at the American Association for the Surgery of TraumaOctober 2, 2023 | Legacy Research (Ad)Elon Did It Again: This Could be Bigger than TeslaLove him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.September 22, 2023 | fool.comAvita Medical (ASX: AVH)September 21, 2023 | finance.yahoo.comAVITA Medical to Present at the Cantor Global Healthcare ConferenceSeptember 15, 2023 | finance.yahoo.comWith 49% stake, AVITA Medical, Inc. (ASX:AVH) seems to have captured institutional investors' interestSeptember 6, 2023 | finance.yahoo.comAVITA Medical to Participate in Upcoming Investor ConferencesAugust 27, 2023 | insidermonkey.com5 Best Cosmetic Surgery and Aesthetics Stocks to BuyOctober 2, 2023 | Legacy Research (Ad)Elon Did It Again: This Could be Bigger than TeslaLove him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.August 23, 2023 | msn.comCantor Fitzgerald Reiterates AVITA Medical (RCEL) Overweight RecommendationAugust 22, 2023 | markets.businessinsider.comExpert Ratings for AVITA MedicalAugust 12, 2023 | finance.yahoo.comAVITA Medical, Inc. (NASDAQ:RCEL) Q2 2023 Earnings Call TranscriptAugust 12, 2023 | msn.comPiper Sandler Maintains AVITA Medical (RCEL) Overweight RecommendationAugust 11, 2023 | investing.comAvita Medical (RCEL) Earnings Dates & ReportsAugust 10, 2023 | finance.yahoo.comAVITA Medical Reports Second Quarter Financial ResultsAugust 2, 2023 | msn.comAVITA Medical (RCEL) Price Target Increased by 14.02% to 26.27July 28, 2023 | msn.comB of A Securities Maintains AVITA Medical (RCEL) Buy RecommendationJuly 20, 2023 | finance.yahoo.comAVITA Medical to Announce Second Quarter 2023 Financial ResultsJuly 16, 2023 | finance.yahoo.comAVITA Medical (ASX:AVH) surges 28% this week, taking five-year gains to 306%July 14, 2023 | finance.yahoo.comStrength Seen in Avita Medical Inc. (RCEL): Can Its 20.4% Jump Turn into More Strength?July 14, 2023 | msn.comLake Street Maintains AVITA Medical (RCEL) Buy RecommendationJuly 6, 2023 | msn.comAVITA Medical (RCEL) Price Target Increased by 7.03% to 23.03June 29, 2023 | finance.yahoo.comAVITA Medical Submits FDA PMA Supplement for RECELL GOJune 27, 2023 | markets.businessinsider.comSkin Grafts Disruption: Avita Medical's Regenerative Medicine System Poised to Disrupt Traditional Skin Grafts, Says AnalystJune 27, 2023 | msn.comCantor Fitzgerald Initiates Coverage of AVITA Medical (RCEL) with Overweight RecommendationJune 26, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Avita Medical (RCEL) and Unicycive Therapeutics (UNCY)June 20, 2023 | markets.businessinsider.comPiper Sandler Remains a Buy on Avita Medical (RCEL)See More Headlines Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address RCEL Company Calendar Last Earnings8/10/2023Today10/01/2023Next Earnings (Estimated)11/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:RCEL CUSIPN/A CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees126Year Founded2008Price Target and Rating Average Stock Price Forecast$28.40 High Stock Price Forecast$40.00 Low Stock Price Forecast$23.00 Forecasted Upside/Downside+94.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-26,670,000.00 Net Margins-74.77% Pretax Margin-74.60% Return on Equity-38.31% Return on Assets-32.40% Debt Debt-to-Equity RatioN/A Current Ratio5.61 Quick Ratio5.39 Sales & Book Value Annual Sales$34.42 million Price / Sales10.82 Cash FlowN/A Price / Cash FlowN/A Book Value$3.39 per share Price / Book4.31Miscellaneous Outstanding Shares25,480,000Free Float24,979,000Market Cap$372.26 million OptionableNot Optionable Beta1.49 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. James M. Corbett (Age 65)CEO, Pres & Exec. Director Comp: $787.1kMr. Andrew Quick (Age 52)Chief Technology Officer Comp: $615.86kMs. Donna Shiroma (Age 61)Gen. Counsel & Sec. Comp: $642.72kMr. David O'TooleChief Financial OfficerMr. David FencilSr. VP of Global OperationsMs. Jessica EkebergInvestor Relations Exec.Ms. Debbie GarnerSr. VP of Global Marketing & StrategyMr. Rob HallSr. VP of HRMr. Terry BromleySr. VP of Global SalesDr. Niraj Doshi J.D.P.M.P., Ph.D., Sr. VP of Product Devel. & Program ManagementMore ExecutivesKey CompetitorsPulmonxNASDAQ:LUNGUtah Medical ProductsNASDAQ:UTMDTactile Systems TechnologyNASDAQ:TCMDCVRxNASDAQ:CVRXAngioDynamicsNASDAQ:ANGOView All CompetitorsInsiders & InstitutionsBarclays PLCBought 5,008 shares on 9/21/2023Ownership: 0.020%Donna ShiromaSold 4,193 sharesTotal: $66,417.12 ($15.84/share)California State Teachers Retirement SystemBought 8,362 shares on 8/21/2023Ownership: 0.033%Nuveen Asset Management LLCBought 84,998 shares on 8/16/2023Ownership: 0.334%David D O'tooleBought 5,000 shares on 8/15/2023Total: $89,650.00 ($17.93/share)View All Insider TransactionsView All Institutional Transactions RCEL Stock - Frequently Asked Questions Should I buy or sell AVITA Medical stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AVITA Medical in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" RCEL shares. View RCEL analyst ratings or view top-rated stocks. What is AVITA Medical's stock price forecast for 2023? 5 brokers have issued twelve-month price objectives for AVITA Medical's shares. Their RCEL share price forecasts range from $23.00 to $40.00. On average, they predict the company's stock price to reach $28.40 in the next twelve months. This suggests a possible upside of 94.4% from the stock's current price. View analysts price targets for RCEL or view top-rated stocks among Wall Street analysts. How have RCEL shares performed in 2023? AVITA Medical's stock was trading at $6.60 at the beginning of 2023. Since then, RCEL shares have increased by 121.4% and is now trading at $14.61. View the best growth stocks for 2023 here. When is AVITA Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our RCEL earnings forecast. How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (NASDAQ:RCEL) announced its quarterly earnings results on Thursday, August, 10th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.07. The business earned $11.75 million during the quarter, compared to the consensus estimate of $11.20 million. AVITA Medical had a negative net margin of 74.77% and a negative trailing twelve-month return on equity of 38.31%. What guidance has AVITA Medical issued on next quarter's earnings? AVITA Medical issued an update on its second quarter 2023 earnings guidance on Thursday, August, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $13.00 million-$14.00 million, compared to the consensus revenue estimate of $12.98 million. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL), Twilio (TWLO), AbbVie (ABBV), Inovio Pharmaceuticals (INO) and Livongo Health (LVGO). What is AVITA Medical's stock symbol? AVITA Medical trades on the NASDAQ under the ticker symbol "RCEL." How do I buy shares of AVITA Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is AVITA Medical's stock price today? One share of RCEL stock can currently be purchased for approximately $14.61. How much money does AVITA Medical make? AVITA Medical (NASDAQ:RCEL) has a market capitalization of $372.26 million and generates $34.42 million in revenue each year. The company earns $-26,670,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. How many employees does AVITA Medical have? The company employs 126 workers across the globe. How can I contact AVITA Medical? AVITA Medical's mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The official website for the company is www.avitamedical.com. The company can be reached via phone at (833) 462-8482 or via email at investor@avitamedical.com. This page (NASDAQ:RCEL) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.